Advanced Search

Technical Analysis for NSPR - InspireMD, Inc.

Grade Last Price % Change Price Change
C 0.8581 -4.66% -0.04
NSPR closed down 4.66 percent on Friday, February 26, 2021, on 53 percent of normal volume.
7 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical NSPR trend table...
Date Alert Name Type % Chg
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -4.66%
Wide Bands Range Expansion -4.66%
Crossed Above 20 DMA Bullish -16.69%
Narrow Range Bar Range Contraction -16.69%
NR7 Range Contraction -16.69%
Wide Bands Range Expansion -16.69%
Fell Below 20 DMA Bearish -8.71%
Wide Bands Range Expansion -8.71%
Older End-of-Day Signals for NSPR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 1 day ago
Up 2% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

InspireMD Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its lead products include MGuard stent, an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent; and MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent. The company markets its products for use primarily in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). It sells its products through distributors in Europe, southeast Asia, India, and Latin America. InspireMD Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Medical Devices Interventional Radiology Southeast Asia Syndromes Bypass Platform Technology Circulatory System Vein Cobalt Interventional Cardiology Heart Attack Infarction Myocardial Infarction Acute Myocardial Infarction Bypass Surgery Stent Embolic Protection Device Percutaneous Coronary Intervention

Is NSPR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 24 InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States
Feb 9 InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States
Feb 8 InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Feb 4 InspireMD shares slide on pricing upsized $18M securities offering
Feb 4 InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering
Feb 3 InspireMD Secures Partner for Intended Registration and Distribution of CGuard EPS in Mainland China
Jan 26 InspireMD’s CGuard™ Featured in Multiple Presentations, Including a Live Case Demonstration During the Leipzig Interventional Congress January 25-29, 2021
Nov 29 Is InspireMD Inc (NSPR) A Good Buy Now?
Nov 11 InspireMD, Inc. (NYSEMKT:NSPR) Just Reported, And Analysts Assigned A US$0.85 Price Target
Nov 9 InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q3 2020 Results - Earnings Call Transcript
See more NSPR news...

Indicators

Indicator Value
52 Week High 1.48
52 Week Low 0.282
Average Volume 19,749,932
200-Day Moving Average 0.51
50-Day Moving Average 0.71
20-Day Moving Average 0.99
10-Day Moving Average 1.06
Average True Range 0.16
ADX 41.79
+DI 30.59
-DI 27.03
Chandelier Exit (Long, 3 ATRs ) 1.01
Chandelier Exit (Short, 3 ATRs ) 1.09
Upper Bollinger Band 1.43
Lower Bollinger Band 0.55
Percent B (%b) 0.35
BandWidth 88.68
MACD Line 0.08
MACD Signal Line 0.12
MACD Histogram -0.0462
Fundamentals Value
Market Cap 31.71 Million
Num Shares 37 Million
EPS -9.91
Price-to-Earnings (P/E) Ratio -0.09
Price-to-Sales 1.52
Price-to-Book 1.17
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.02
Resistance 3 (R3) 1.02 0.97 0.99
Resistance 2 (R2) 0.97 0.93 0.97 0.98
Resistance 1 (R1) 0.92 0.91 0.89 0.91 0.97
Pivot Point 0.87 0.87 0.86 0.87 0.87
Support 1 (S1) 0.81 0.83 0.79 0.81 0.74
Support 2 (S2) 0.76 0.80 0.76 0.74
Support 3 (S3) 0.71 0.76 0.73
Support 4 (S4) 0.70